On the central mediation of anorexigenic drug effects.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001066:Appetite / Q000187:drug effects; D001067:Appetite Depressants / Q000494:pharmacology*; D002490:Central Nervous System / Q000502:physiology*; D002713:Chlorine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004221:Disulfiram / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D010134:Fenclonine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D008781:Methyltyrosines / Q000037:antagonists & inhibitors; D009638:Norepinephrine / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors
D001067:Appetite Depressants; D008781:Methyltyrosines; D011950:Receptors, Cholinergic; D012701:Serotonin; D002713:Chlorine; D006897:Hydroxyindoleacetic Acid; D011433:Propranolol; D000661:Amphetamine; D006220:Haloperidol; D010134:Fenclonine; D004221:Disulfiram; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine